Rick Sontheimer, MD In his presentation, Dr Sontheimer summarized recent observations characterizing drug-induced SCLE (DI-SCLE). In 1977 he and Jim Gilliam co-authored along with the seminal paper on SCLE. Dr. Sontheimer suggests that when a physician sees a new SCLE patient it is important to ask whether it is idiopathic SCLE or is this a […]
Joel Cohen, MD; Director, About Skin Dermatology and DermSurgery; Englewood and Lonetree, Colorado Dermatologists across the country are using dermal fillers on a daily basis and the products available in the US are believed to be safe and effective provided that they are used correctly. In his presentation, Dr. Joel Cohen discussed the importance of understanding, avoiding […]
Panelists: James DelRosso, MD; Alan Shalita, MD; Guy Webster, MD, PhD The diagnosis of rosacea is based upon clinical findings; there are no specific diagnostic tests. The National Rosacea Society Expert Committee on the classification and staging of rosacea has developed provisional diagnostic guidelines for rosacea.1 The guidelines recommend the presence of one or more […]
Dr. Avram points out that clinicians need to remember that fat and cellulite need to be considered as distinct problems. Fat removal technologies may have no result on cellulite and vice versa. This presentation focuses on fat removal processes and tissue tightening.
Diagnosing psoriatic arthritis (PsA) in our patients with psoriasis remains a challenge. Rheumatologist Dr Kavanaugh discusses the latest data around assessing and treating patients with PsA.
How does a dermatologist evaluate the wide array of cosmeceutical products available? What really works for our patients? Dr Gold presents the pivotal studies for emerging products in the “anti-aging space” and adds his perspective on topical therapies for skin issues ranging from wrinkles, hyperpigmentation to redness…
In the US, nearly 60% of “at risk” individuals over the age of 40 have at least 1 AK. In this presentation, Dr Martin addresses the spectrum of current available therapies and how to best optimize patient outcomes.
Dr. Leonardi explains why it is important to consider possible adverse events, specifically cardiovascular events, which can affect treatment decisions for psoriasis patients. What did the recent JAMA article conclude? 4-year safety data on ustekinumab summarized….
Dr Gilchrest addresses the questions as to what is aging skin and what does it mean? “The process of aging and photoaging are consequences of safeguarding the genome”.
Administrative Office
Maui Derm
161 Wailea Ike Place, Suite A-104
Kihei, HI 96753
Stay Connected
Sign up to receive updates about upcoming meetings.